| Market Cap | 579.72M | P/E | - | EPS this Y | 15.30% | Ern Qtrly Grth | - |
| Income | -39.84M | Forward P/E | -11.36 | EPS next Y | -6.00% | 50D Avg Chg | 1.00% |
| Sales | 76.86M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 29.00% |
| Dividend | N/A | Price/Book | 12.89 | EPS next 5Y | - | 52W High Chg | -3.00% |
| Recommedations | 2.50 | Quick Ratio | 1.82 | Shares Outstanding | 47.55M | 52W Low Chg | 187.00% |
| Insider Own | 4.29% | ROA | -14.39% | Shares Float | 39.54M | Beta | 2.32 |
| Inst Own | 63.41% | ROE | -84.92% | Shares Shorted/Prior | 462.09K/566.21K | Price | 10.00 |
| Gross Margin | 55.20% | Profit Margin | -51.84% | Avg. Volume | 1,313,430 | Target Price | 10.00 |
| Oper. Margin | -36.20% | Earnings Date | Jul 31 | Volume | 1,639,528 | Change | 0.00% |
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
| Cowen & Co. | Market Perform | Jan 23, 23 |
| Stifel | Hold | Jan 4, 23 |
| Lake Street | Hold | Nov 30, 22 |
| Stephens & Co. | Overweight | May 4, 22 |
| Stifel | Buy | Feb 23, 22 |
| Cowen & Co. | Outperform | Dec 15, 21 |
| Stifel | Buy | Dec 9, 21 |
| Stephens & Co. | Overweight | Sep 9, 21 |
| Piper Sandler | Overweight | Jun 14, 21 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Black Jeffrey G. | Chief Financial Offi.. Chief Financial Officer | Feb 25 | Buy | 5.78 | 40,000 | 231,200 | 265,000 | 03/01/22 |
| CPMG Inc | 10% Owner 10% Owner | Oct 15 | Buy | 7.75 | 683,871 | 5,300,000 | 2,151,209 | 10/19/21 |
| McGaughy R Kent Jr | Director Director | Oct 15 | Buy | 7.75 | 683,871 | 5,300,000 | 2,151,209 | 10/19/21 |
| McKhann Chas | President and CEO President and CEO | Aug 20 | Sell | 7.95 | 63,452 | 504,443 | 643,826 | 08/20/21 |
| Black Jeffrey G. | Chief Financial Offi.. Chief Financial Officer | Aug 11 | Buy | 8.75 | 25,000 | 218,750 | 25,000 | 08/11/21 |